# Grand Pharma and Donghai Capital to form joint venture for cardiovascular medical devices

Grand Pharmaceutical Group (00512) announced plans to form a joint venture in Hong Kong with Donghai Capital, a subsidiary of its controlling shareholder China Grand Enterprises. The JV, with a total investment of about $15 million, will focus on selling cardiovascular medical devices, including investing in North American manufacturers and establishing sales channels in China.

- Type: Partnership
- Announced: 2017-11-13
- Where: Hong Kong, Hong Kong SAR China
- Value: $15.0M
- Status: announced
- Products: cardiovascular medical devices, angiography equipment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Grand Pharmaceutical Group](https://endata.com/companies/28076.md) (partner)
- [Donghai Capital](https://endata.com/companies/28077.md) (partner)
- [China Grand Enterprises](https://endata.com/companies/28078.md) (investor)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/90717.html), 2017-11-13: "2017年11月13日，公司拟与控股股东中国远大旗下东海资本，在香港成立合营企业，其中，由公司持有不多于49.9%股本权益。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.